ETR:AFX Carl Zeiss Meditec Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Carl Zeiss Meditec AG Please log in to your account or sign up in order to add this asset to your watchlist. €115.75 +1.85 (+1.62%) (As of 07/1/2022 12:00 AM ET) Add Compare Share Today's Range€111.25▼€115.7550-Day Range€105.45▼€129.9552-Week Range€104.55▼€202.00Volume67,330 shsAverage Volume94,405 shsMarket Capitalization$10.35 billionP/E Ratio38.46Dividend Yield0.78%Price Target€181.13 ProfileAnalyst RatingsChartCompetitorsHeadlines Carl Zeiss Meditec MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside56.5% Upside€181.13 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.1.16 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €181.13, Carl Zeiss Meditec has a forecasted upside of 56.5% from its current price of €115.75.Amount of Analyst CoverageCarl Zeiss Meditec has received no research coverage in the past 90 days. Previous Next 0.0 Short Interest Short InterestThere is no current short interest data available for AFX. Previous Next 0.8 Dividend Strength Dividend YieldCarl Zeiss Meditec has a dividend yield of 0.78%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCarl Zeiss Meditec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Carl Zeiss Meditec is 29.90%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AFX. Previous Next 1.1 News and Social Media Coverage News SentimentCarl Zeiss Meditec has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Carl Zeiss Meditec this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Carl Zeiss Meditec is 38.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 74.87.Price to Earnings Ratio vs. SectorThe P/E ratio of Carl Zeiss Meditec is 38.46, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.11.Price to Earnings Growth RatioCarl Zeiss Meditec has a PEG Ratio of 3.89. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCarl Zeiss Meditec has a P/B Ratio of 5.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter. Email Address About Carl Zeiss Meditec (ETR:AFX) StockCarl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.Read More AFX Stock News HeadlinesJune 29, 2022 | americanbankingnews.comCarl Zeiss Meditec (ETR:AFX) Given a €156.00 Price Target by Deutsche Bank Rese... AnalystsApril 8, 2022 | finanznachrichten.deCarl Zeiss Meditec AG: ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software ApplicationsJuly 4, 2021 | finance.yahoo.comCARL ZEISS MEDITEC AG (AFX.DE) stock forecast and price targetJune 14, 2021 | bizjournals.comAfter passing Covid test, Peninsula diagnostics company refocuses on the eye with new CEOApril 14, 2021 | marketwatch.comNear-Infrared Imaging Market Size Worth USD 1,535.0 Million in 2028, Market Trends – Increasing geriatric populationFebruary 12, 2021 | marketwatch.comMedical Device Contract Manufacturing Market Size, Share to Grow Tremendously During 2020-2027 Industry News | ARCFebruary 9, 2021 | seekingalpha.comCarl Zeiss Meditec AG (CZMWF) CEO Ludwin Monz on 3-Months Quarterly Statement Conference Call 2021 Results - Earnings Call TranscriptJanuary 26, 2021 | marketwatch.comIntraoperative Radiation Therapy Systems Market Development by Gross Margin, Market Share, CAGR, and Influencing Factors and Forecast To 2025January 19, 2021 | nasdaq.comCarl Zeiss Meditec Q1 Profit Rises - Quick FactsJanuary 2, 2021 | marketwatch.comOphthalmic Ultrasound Systems Market (2020-29): Product Analysis, Market Statistics and Immense Report | Ametek Inc, Carl Zeiss Meditec AGDecember 11, 2020 | seekingalpha.comCarl Zeiss Meditec AG (CZMWF) CEO Ludwin Monz on Q4 2020 Results - Earnings Call TranscriptNovember 11, 2020 | marketwatch.comMedical Workstations Market Growth Opportunities, Industry Analysis, Size, Share, Geographic Segmentation Till 2027 By Reports And DataNovember 9, 2020 | marketwatch.comMultifocal Intraocular Lens Market 2020 includes Size, Share, Impact of COVID-19, Trends and Forecast to 2026 Research Report by Absolute ReportsOctober 29, 2020 | nasdaq.comCarl Zeiss Meditec Q4 EBIT Declines - Quick FactsOctober 17, 2020 | ca.finance.yahoo.comCARL ZEISS MEDITEC AG (AFX.MU)October 16, 2020 | ca.finance.yahoo.comCARL ZEISS MEDITEC AG (AFX.DU)August 16, 2020 | ca.finance.yahoo.comCarl Zeiss Meditec AG Inhaber-A (AFX.SG)July 20, 2020 | www.marketwatch.comSouth Korean Ophthalmic Devices Market Demand, Production and Company Overview to 2025July 15, 2020 | www.nasdaq.comCarl Zeiss Meditec 9-month EBIT Declines; Adj. Revenue Down 6.9% - Quick FactsMay 15, 2020 | uk.finance.yahoo.comDisentangling the effect of Covid-19 on Carl Zeiss Meditec Ag's share priceMay 15, 2020 | finance.yahoo.comCarl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowMay 15, 2020 | finance.yahoo.comCarl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting NowMay 11, 2020 | www.reuters.comBRIEF-Carl Zeiss Meditec Says Significant Slowdown In Q2 Due To Covid-19May 11, 2020 | www.nasdaq.comCarl Zeiss Meditec H1 EPS Up, EBIT, Margin Down - Quick FactsMay 8, 2020 | www.marketwatch.comCOVID-19 Impact on Optical Imaging Market Size 2020 Top Manufactures Analysis by St. Jude Medical, Carl Zeiss Meditec, Leica MicrosystemSee More Headlines Industry, Sector and Symbol Stock ExchangeETR Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolETR:AFX CUSIPN/A CIKN/A Webwww.zeiss.com Phone+49-3641-2200FaxN/AEmployees3,531Year FoundedN/ACompany Calendar Today7/04/2022Next Earnings (Estimated)8/05/2022Price Target and Rating Average Stock Price Forecast€181.13 High Stock Price Forecast€215.00 Low Stock Price Forecast€146.00 Forecasted Upside/Downside+56.5%Consensus RatingN/A Rating Score (0-4)0 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio38.46 Forward P/E Ratio35.25 P/E Growth3.89Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.84 Current Ratio3.35 Quick Ratio2.62 Sales & Book Value Annual Sales$1.73 billion Price / Sales5.97 Cash Flow€0.09 per share Price / Cash Flow1,231.38 Book Value€19.34 per share Price / Book5.98Miscellaneous Outstanding Shares89,440,600Free FloatN/AMarket Cap$10.35 billion OptionableNot Optionable BetaN/A Carl Zeiss Meditec Frequently Asked Questions What is Carl Zeiss Meditec's stock price forecast for 2022? 0 Wall Street research analysts have issued 1 year price objectives for Carl Zeiss Meditec's shares. Their AFX stock forecasts range from €146.00 to €215.00. On average, they anticipate Carl Zeiss Meditec's stock price to reach €181.13 in the next year. This suggests a possible upside of 56.5% from the stock's current price. View analysts' price targets for Carl Zeiss Meditec or view top-rated stocks among Wall Street analysts. How has Carl Zeiss Meditec's stock price performed in 2022? Carl Zeiss Meditec's stock was trading at €184.85 at the beginning of the year. Since then, AFX shares have decreased by 37.4% and is now trading at €115.75. View the best growth stocks for 2022 here. When is Carl Zeiss Meditec's next earnings date? Carl Zeiss Meditec is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Carl Zeiss Meditec. Is Carl Zeiss Meditec a good dividend stock? Carl Zeiss Meditec(ETR:AFX) pays an annual dividend of €0.90 per share and currently has a dividend yield of 0.78%. The dividend payout ratio of Carl Zeiss Meditec is 29.90%. This payout ratio is at a healthy, sustainable level, below 75%. Who are Carl Zeiss Meditec's key executives? Carl Zeiss Meditec's management team includes the following people: Mr. Justus Felix Wehmer, CFO & Member of the Management Board (Age 57, Pay $564.5k)Mr. Jan Willem de Cler, Member of Management BoardDr. Markus Weber, Pres, CEO & Chairman of Management BoardMr. Sebastian Frericks, Director of Investor RelationsMr. Martin Wiechmann, Head of the Planetarium Bus. UnitMr. Mike Wang, Head of Marketing - ShanghaiMr. Steven C. Schallhorn M.D., Chief Medical Officer for Global Ophthalmic DevicesMr. Andrew Chang, Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.Laurie Ferguson, Head of Global Communications Ophthalmic DevicesDr. Euan S. Thomson Ph.D., Pres of Ophthalmic Devices & Head of the Ophthalmic Devices Strategic Bus. Unit (Age 59) Who are some of Carl Zeiss Meditec's key competitors? Some companies that are related to Carl Zeiss Meditec include Sartorius Aktiengesellschaft (SRT), Sernova (SVA), MaxCyte (MXCT), Profound Medical (PRN), Profound Medical (PRN), Renalytix (RENX), Akumin (AKU), SQI Diagnostics (SQD), Oncimmune (ONC), Yourgene Health (YGEN), VentriPoint Diagnostics (VPT), Verici Dx (VRCI), Cambridge Cognition (COG), GeneNews (GEN) and LexaGene (LXG). View all of AFX's competitors. What other stocks do shareholders of Carl Zeiss Meditec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP). What is Carl Zeiss Meditec's stock symbol? Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX." What is Carl Zeiss Meditec's stock price today? One share of AFX stock can currently be purchased for approximately €115.75. How much money does Carl Zeiss Meditec make? Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $10.35 billion and generates $1.73 billion in revenue each year. How many employees does Carl Zeiss Meditec have? Carl Zeiss Meditec employs 3,531 workers across the globe. How can I contact Carl Zeiss Meditec? Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for Carl Zeiss Meditec is www.zeiss.com. The company can be reached via phone at +49-3641-2200. This page (ETR:AFX) was last updated on 7/4/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
